H I Levitsky - JoVE Visualize

Showing results (21-30 of 32) with videos related to

Pageof 4

Sort By:

Science (New York, N.Y.)|November 1, 1991

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4P T Golumbek, A J Lazenby, H I Levitsky, et al.

Cell Transplantation|January 1, 1996

Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblastsS W Robinson, P W Cho, H I Levitsky, et al.

Nature Medicine|July 8, 1999

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40E M Sotomayor, I Borrello, E Tubb, et al.

Cancer Research|January 1, 1996

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigenK Y Lin, F G Guarnieri, K F Staveley-O'Carroll, et al.

International Journal of Oncology|February 10, 1998

Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccinesA Nigam, R F Yacavone, M L Zahurak, et al.

Cell|February 9, 1990

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseE R Fearon, D M Pardoll, T Itaya, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigensT C Wu, F G Guarnieri, K F Staveley-O'Carroll, et al.

Blood Cancer Journal|September 10, 2013

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapyL Qin, B D Smith, H-L Tsai, et al.

Cancer Immunology, Immunotherapy : CII|November 17, 2010

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondC M Britten, S Janetzki, S H van der Burg, et al.

Cancer Research|April 15, 1997

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transferJ W Simons, E M Jaffee, C E Weber, et al.

Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:

Pageof 4

Science (New York, N.Y.)|November 1, 1991

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4P T Golumbek, A J Lazenby, H I Levitsky, et al.

Cell Transplantation|January 1, 1996

Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblastsS W Robinson, P W Cho, H I Levitsky, et al.

Nature Medicine|July 8, 1999

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40E M Sotomayor, I Borrello, E Tubb, et al.

Cancer Research|January 1, 1996

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigenK Y Lin, F G Guarnieri, K F Staveley-O'Carroll, et al.

International Journal of Oncology|February 10, 1998

Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccinesA Nigam, R F Yacavone, M L Zahurak, et al.

Cell|February 9, 1990

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseE R Fearon, D M Pardoll, T Itaya, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigensT C Wu, F G Guarnieri, K F Staveley-O'Carroll, et al.

Blood Cancer Journal|September 10, 2013

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapyL Qin, B D Smith, H-L Tsai, et al.

Cancer Immunology, Immunotherapy : CII|November 17, 2010

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyondC M Britten, S Janetzki, S H van der Burg, et al.

Cancer Research|April 15, 1997

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transferJ W Simons, E M Jaffee, C E Weber, et al.

Pageof 4